Few non-invasive biomarkers indirectly associated with fibrosis stages in NASH, such as FIB-4, aspartate aminotransferase (AST)/Alanine aminotransferase (ALT) ratio and NAFLD Fibrosis Score (NFS), have been extensively studied8–11. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.